BOLETIN BIBLIOGRAFICO
BIBLIOTECA MEDICA-HOSPITAL MEXICO
SETIEMBRE 2005
1. Fiebre amarilla : un peligro latente.
En: Acta Méd Cost 47 (3): 118-125, jul-set. 2005
2. Patología de la hipertensión arterial, rol de Angiotensina II, Oxido Nítrico y Endotelina.
En: Acta Méd Cost 47 (3): 109-117, jul-set. 2005
3. A symposium : Immune activation and inflammation in chronic heart failure : A review of potential treatment strategies.
En: Am J Cardiol 95 (11 Supl): jun. 2005
4. Role of plant stanol esters in cholesterol management : Enchancing the efficacy of diet and statin therapy.
En: Am J Cardiol 96 (1A): jul. 2005
5. Survivin as a marker of cervical intraepithelial neoplasia and high-risk-human papilomavirus and a predictor of virus clearance and prognosis in cervical cancer.
En: Am J Clin Pathol 124 (1): 113-122, jul. 2005
6. Pharmacologic treatment of type 2 diabetes mellitus.
En: Am J Med 118 (5A): mayo. 2005
7. Quantitative assessment of trombus burden predicts the outcome of treatment for venous thrombosis : A systematic review.
En: Am J Med 118 (5): 456-474, mayo. 2005
8. Recent advances in mechanical ventilation.
En: Am J Med 118 (6): 584-591, jun. 2005
9 Recommendations for accurate prescribing of antibiotics : Council for appropriate and rational antibiotic therapy.
En: Am J Med 118 (7A): jul. 2005
10. Update on the treatment of hypertension.
En: Am J Med 118 (7): 695-714, jul. 2005
11. Have we forgotten the significance of postpartum iron deficiency?
En: Am J Obstet Gynecol 193 (1): 36-44, jul. 2005
12. Optimizing pregnancy outcomes in minority populations.
En: Am J Obstet Gynecol 192 (5 Supl): mayo. 2005
13. Colorectal manifestations of collager vascular disease.
En: Am J Surg 189 (6): 685-693, jun. 2005
14. Laparoscopic transhiatal esophagectomy for esophageal cancer.
En: Am J Surg 190 (1): 69-74, jul. 2005
15. Vascular occlusion to decrease blood loss during hepatic resection.
En: Am J Surg 190 (1): 75-86, jul. 2005
16. Primer of postoperative pruritus for anesthesiologists.
En: Anesthesiology 103 (1): 168-178, jul. 2005
17. Antibiotic prophylaxis reduces mortality in neutropenic patients.
En: Ann Intern Med 142 (12 Part 1): 979-995, jun. 2005
18. Challenges of summarizing better information for better health : The evidence-based practice center experience.
En: Ann Intern Med 142 (12 Part 2): jun. 2005
19. Continuing controversies in the management of thyroid nodules.
En: Ann Intern
Med 142 (11): 926-931, jun. 2005
20. Meta-analysis : Accuracy of rapid tests for Malaria in travelers returning from endemic areas.
En: Ann Intern Med 142 (10): 836-846, mayo, 2005
21. Noninvasive testing for chlamydia trachomatis and neisseria gonorrhoea.
En: Ann Intern Med 142 (11): 914-925, jun. 2005
22. The valve of clinical assessment in the diagnosis of deep venous thrombosis.
En: Ann Intern
Med 143 (2): 128-139, jul. 2005
23. Systematic appraisal of the role of metallic endobiliary stents in the treatment of benign bile duct stricture.
En: Ann Surg 242 (1): 10-19, jul. 2005
24. Actitudes para fomentar el cumplimiento terapéutico en el asma.
En: Arch Bronconeu 41 (6): 334-340, jun. 2005
25. Disfunción endotelial en la hipertensión pulmonar.
En: Arch Bronconeu 41 (7): 389-392, jul. 2005
26. Estrés oxidativo y síndrome de apneas hipopneas del sueño.
En: Arch Bronconeu 41 (7): 393-400, jul. 2005
27. American pain society recommendations for improving the quality of acute and cancer pain management.
En: Arch Intern Med 165 (14): 1574-1580, jul. 2005
28. Is proton pump inhibitors testing an effective approach to diagnose gastroesophageal reflux disease in patients with noncardiac chest pain? A meta-analysis.
En: Arch Intern Med 165 (11): 1222-1228, jun. 2005
29. Risk of hospitalization for myocardial infarction among users of Rotacoxib, Celecoxib, and other NSAIDS : A population-based case control study.
En: Arch Intern Med 165 (9): 978-985, mayo. 2005
30. Systematic review and meta-analysis of short.Acting insulin analogues in patients with diabetes mellitus.
En: Arch Intern Med 165 (12): 1337-1346, jun. 2005
31. ABC of conflict and disaster : Displaced populations and long term humanitarian assistance.
En: BMJ 331 (7508): 98-100, jul. 2005
32. ABC of conflict and disaster : Humanitarian assistance : standars, skills, training, and experience.
En: BMJ 330 (7501): 1199-1201, mayo. 2005
33. ABC of conflict and disaster : Military approach to medical planning in humanitarian operations.
En: BMJ 330 (7505): 1437-1439, jun. 2005
34. ABC of conflict and disaster : Natural disasters.
En: BMJ 330 (7502): 1259-1261, mayo. 2005
35. ABC of conflict and disasters : Needs assessment of humanitarian crises.
En: BMJ 330 (7503):9 1320-1322, jun. 2005
36. ABC of conflict and disaster : Principles of war surgery.
En: BMJ 330 (7506): 1498-1500, jun. 2005
37. ABC of conflict and disaster : Psychological aspects of providing medical humanitarian aid.
En: BMJ 331 (7509): 152-154, jul. 2005
38. ABC of conflict and disaster : Public health in the aftermath of disasters.
En: BMJ 330 (7504): 1379-1381, jun. 2005
39. ABC of conflict and disaster : The special needs of children and women.
En: BMJ 331 (7507): 34-36, jul. 2005
40. ABC of emergency radiology : Major trauma.
En: BMJ 330 (7500): 1136-1138, mayo, 2005
41. Basic transthoracic echocardiography.
En: BMJ 330 (7505): 1432-1436, jun. 2005
42. Managing ophthalmic herpes zoster in primary care.
En: BMJ 331 (7509): 147-151, jul. 2005
43. Pregnancy and breast cancer.
En: BMJ 330 (7504): 1375-1378, jun. 2005
44. Radiological review of pneumothorax.
En: BMJ 330 (7506): 1493-1497, jun. 2005
45. Epidermal growth factor receptor-targeted treatment for advanced colorectal carcinoma.
En: Cancer 103 (12): 2435-2446, jun. 2005
46. 5-Hydroxytryptamine type-3 receptor antagonists for chemotherapy induced and radiotherapy- induced-nausea and emesis : Can we safety reduce the dose of administered agents?
En: Cancer 104 (1): 1-13, jul. 2005
47. Aerosolized magnesium sulfate for acute asthma : A systematic review.
En: Chest 128 (1): 337-344, jul. 2005
48. Cortical substrates for the perception of dyspnea.
En: Chest 128 (1): 345-354, jul. 2005
49. Improving the ICU. Part I.
En: Chest 127 (6): 2151-2164, jun. 2005
50. Improving the ICU : Part 2.
En: Chest 127 (6): 2165-2179, jun. 2005
51. Lung cancer in women : emerging differences in epidemiology biology, and therapy.
En: Chest 128 (1): 370-382, jul. 2005
52. Outcomes of elderly survivors of intensive care: A review of the literature.
En: Chest 127 (5): 1764-1774, mayo, 2005
53. Cardiovascular effects of secondhand smoke.
En: Circulation
111 (20): 2684-2698, mayo. 2005
54. Current concepts of the pathogenesis and treatment of hypertrophic cardiomyopathy.
En: Circulation
112 (2): 293-296, jul. 2005
55. Metaloproteasas en aterosclerosis : Implicaciones fisiopatológicas y terapéuticas.
En: Clin Invest Arterioscl 17 (3): 133-141, mayo-jun. 2005
56. Management of abnormal uterine bleeding.
En: Clin Obstet Gynecol 48 (2): jun, 2005
57. New developments in preeclampsia.
En: Clin Obstet Gynecol 48 (2): jun. 2005
58. Mechanical ventilation and acute renal failure.
En: Crit Care Med 33 (6): 1408-1415, jun. 2005
59. Regional analgesia in the critically ill.
En: Crit Care Med 33 (6): 1400-1407, jun. 2005
60. Hereditary colon cancer - Part II.
En: Curr Probl Surg 42 (5): mayo. 2005
61. Peptic ulcer disease.
En: Curr Probl Surg 42 (6): jun. 2005
62. Transplante renal en pacientes infectados por el VIH.
En: Enferm Infecc Microbiol Clin 23 (6): 363-374, jun-jul. 2005
63. Collagenous mucosal inflammatory disease of the gastrointestinal tract.
En: Gastroenterology 129 (1): 338-350, jul. 2005
64. Gastrointestinal cancer : Mechanisms, diagnosis, and treatment.
En: Gastroenterology 128 (6): mayo, 2005
65. Mass screening with CT colonography : Should the radiation exposure be of concern?.
En: Gastroenterology 129 (1): 328-337, jul. 2005
66. Are somatosensory evoked potentials the best predictor of outcome after severe brain injury? A systematic review.
En: Intensive Care Med 31 (6): 765-775, jun. 2005
67. Quality of life in adult survivors of critical illness : A systematic review of the literature.
En: Intensive Care Med 31 (5): 611-620, mayo. 2005
68. Alterations in gastrointestinal physiology after Roux-En-Y gastric bypass.
En: J Am Coll Surg 201 (1): 125-131, jul. 2005
69. Areola-Sparing mastectomy : defining the risks.
En: J Am Coll Surg 201 (1): 118-124, jul. 2005
70. Mechanisms of ventral hernia recurrence after mesh repair and new proposed classification.
En: J Am Coll Surg 201 (1): 132-141, jul. 2005
71. Schistosomal portal hypertension.
En: J Am Coll Surg 200 (9): 795-806, mayo, 2005
72. Symposium on surgery in the elderly patient, Part 2.
En: J Am Coll Surg 200 (5): 766-794, mayo, 2005
73. Bone morphogenetic proteins.
En: J Bone Joint Surg 87A (6): 1367-1378, jun. 2005
74. Pediatrics.
En: J Neurosurg 103 (Supl. 1): jul. 2005
75. Spine.
En: J Neurosurg 3 (1): jul. 2005
76. Update of proceedings of the 2002 international, workshop on osteoarthritis outcomes.
En: J Rheumatol 32 (6): 1131-1159, jun. 2005
77. Current role of artificial urinary sphineter for treatment of urinary incontinence.
En: J Urol 174 (2): 418-424, ago. 2005
78. How little is enough? evidence for post-vasectomy testing.
En: J Urol 174 (1): 29-36, jul. 2005
79. Impact of provider volume on outcomes from urological cancer therapy.
En: J Urol 174
(2): 432-438, ago. 2005
80. Is ortholopic bladder replacement new gold standard? Evidence from systematic review.
En: J Urol 174 (1): 21-28, jul. 2005
81. Measuring quality of care for localized prostate cancer.
En: J Urol 174 (2): 425-431, ago. 2005
82. Renal cell carcinoma 2005 : New frontiers in staging, prognostication, and targeted molecular therapy.
En: J Urol 173 (6): 1853-1862, jun. 2005
83. Update on chemotherapy for advanced bladder cancer.
En: J Urol 174 (1): 14-20, jul. 2005
84. Androgen deprivation therapy for prostate cancer.
En: JAMA 294 (2): 238-244, jul. 2005
85. Coffee consumption and risk of type 2 diabetes : A systematic review.
En: JAMA 294 (1): 97-104, jul. 2005
86. Effects of antibiotics therapy on outcomes of patients with coronary artery disease : A meta-analysis of randomized controlled trials.
En: JAMA 293 (21): 2641-2653, jun. 2005
87. Efficacy and safety of opioid agonists in the treatment of neuropathic pain of nonmalignant origin : Systematic review and meta-analysis of randomized controlled trials.
En: JAMA 293 (24): 3043-3069, jun. 2005
88. Fracture prevention with Vitamin D supplementation : A meta-analysis of randomized controlled trials.
En: JAMA 293 (18): 2257-2264, mayo. 2005
89. Neonatal signs after late in utero exposure to serotonin reuptake inhibitors : Literature review and implications for clinical applications.
En: JAMA 293 (19): 2372-2383, mayo, 2005
90. Personal use of hair dyes and risk of cancer : A meta-analysis.
En: JAMA 293 (20): 2516-2525, mayo. 2005
91. Routine vs Selective invasive strategies in patients with acute coronary syndromes : A collaborative meta-analysis of randomized trials.
En: JAMA 293 (23): 2908-2924, jun. 2005
92. Acute rheumatic fever.
En: Lancet 366 (9480): 155-168, jul. 2005
93. Aplastic anaemia.
En: Lancet 365 (9471): 1647-1656, mayo. 2005
94. Attention deficit hyperactivity disorder.
En: Lancet 366 (9481): 237-248, jul. 2005
95. Breast cancer.
En: Lancet 365 (9472): 1727-1741, mayo. 2005
96. Congenital adrenal hyperplasia.
En: Lancet 365 (9477): 2125-2136, jun. 2005
97. Depression in the elderly.
En: Lancet 365 (9475): 1961-1970, jun. 2005
98. Multiple birth resulting from ovarian stimulation for subfertility treatment.
En: Lancet 365
(9473): 1807-1816, mayo. 2005
99. Nasopharyngeal carcinoma.
En: Lancet 365 (9476): 2041-2054, jun. 2005
100. Palliative care in sub-Saharan Africa.
En: Lancet 365 (9475): 1971-1977, jun. 2005
101. Pemphigus.
En: Lancet 366 (9479): 61-73, jul. 2005
102. Q1-antitrypsia deficiency
En: Lancet 365 (9478): 2225-2236, jul. 2005
103. Seminar heart failure.
En: Lancet 365 (9474): 1877-1889, mayo-jun. 2005
104. Sjögren's syndrome.
En: Lancet 366 (9482): 321-334, jul. 2005
105. Somatostatin analogues in the treatment of gastroesteropancreatic neuroendocrine tumors.
En: Mayo Clin Proc 80 (4): 502-510, abr. 2005
106. Subarachnoid hemorrhage : Neurointensive care and aneurysm repair.
En: Mayo Clin Proc 80 (4): 550-562, abr. 2005
107. Fibrinógeno, vieja proteína hemostática con nueva función : marcador no invasivo de ateriosclerosis subclínica.
En: Med Clin 124 (20): 790-794, mayo. 2005
108. Indicaciones y consecuencias de la erradicación de helicobacter pylori en la enfermedad por reflujo gastroesofágico.
En: Med Clin 124 (18): 697-709, mayo. 2005
109. Interacciones farmacológicas de los fármacos antihipertensivos.
En: Med Clin 124 (20): 782-789, mayo, 2005
110. Patogenía de la hepatopatía grasa no alcohólica primaria.
En: Med Clin 124 (17): 668-677, mayo. 2005
111. Utilidad del dimero D en la enfermedad tromboembólica venosa.
En: Med Clin 124 (19): 749-753, mayo. 2005
112. Minority health and disparities-related issues : Part I.
En: Med Clin North Am 89 (4): jul. 2005
113. Papel de la microcirculación en el desarrollo de la lesión pulmonar aguda inducida por la ventilación mecánica.
En: Med Intensiva 29 (4): 226-235, mayo. 2005
114. Enfermedades oncológicas I.
En: Medicine 9 (24): ene. 2005
115. Enfermedades oncológicas II.
En: Medicine 9 (25): feb. 2005
116. Enfermedades oncológicas III.
En: Medicine 9 (26): feb. 2005
117. Enfermedades oncológicas IV.
En: Medicine 9 (27): mar. 2005
118. Enfermedades del sistema inmune I.
En: Medicine 9 (28): mar. 2005
119. Enfermedades del sistema inmune II.
En: Medicine 9 (29): abr. 2005
120. Enfermedades del sistema inmune III.
En: Medicine 9 (30): abr. 2005
121. Enfermedades del sistema inmune IV.
En: Medicine 9 (31): abr. 2005
122. Enfermedades del sistema inmune V.
En: Medicine 9 (32): mayo, 2005
123. Enfermedades del sistema inmune VI.
En: Medicine 9 (33): mayo. 2005
124. Enfermedades del sistema inmune VII.
En: Medicine 9 (34): mayo. 2005
125. Enfermedades cardiovasculares I.
En: Medicine 9 (35): jun. 2005
126. Brucellosis.
En: N Engl J Med 352 (22): 2325-2336, jun. 2005
127. Calpains and disease.
En: N Engl J Med 352 (23): 2413-2423, jun. 2005
128. Children with discontinuous insurance coverage.
En: N Engl J Med 353 (4): 382-391, jul. 2005
129. Current concepts : Benign breast disorders.
En: N Engl J Med 353 (3): 275-285, jul. 2005
130. Cystic Fibrosis.
En: N Engl J Med 352 (19): 1992-2001, mayo. 2005
131. Drug metabolism and variability among patients in drug response.
En: N Engl J Med 352 (21): 2211-2221, mayo. 2005
132. Potential options for preservation of fertility in women.
En: N Engl J Med 353 (1): 64-73, jul. 2005
133. Prevalence and treatment of mental disorders, 1990 to 2003.
En: N Engl J Med 352 (24): 2515-2523, jun. 2005
134. Tyrosine kinases as targets for cancer therapy.
En: N Engl J Med 353 (2): 172-187, jul. 2005
135. y-Hydroxybutyric acid.
En: N Engl J Med
352 (26): 2721-2732, jun. 2005
136. Vertebrobasilar disease.
En: N Engl J Med 352 (25): 2618-2626, jun. 2005
137. From migraine mechanisms to innovative therapeutic drugs.
En: Neurology 64 (10 Supl. 2): mayo. 2005
138. Implications of stroke preventions trials : treatment of global risk.
En: Neurology 65 (1): 17-21, jul. 2005
139. Pseudoneurotoxic disease.
En: Neurology 65 (1): 22-26, jul. 2005
140. The spectrum of presentations of venous infarction caused by deep cerebral vein thrombosis.
En: Neurology 65 (2): 192-196, jul. 2005
141. Transdernal delivery of dopaminergic agents.
En: Neurology 65 (2 Supl. 1): jul. 2005
142. Pituitary carcinoma : A Clinicopathological review.
En: Neurosurgery 56 (5): 1066-1074, mayo. 2005
143. Assessing the neonatal safety of indomethacin tocolysis : A systematic review with meta-analysis.
En: Obstet Gynecol 106 (1): 173-180, jul. 2005
144. Cerclage for short cervix on ultrasonography : Meta-analysis of trials using individual patient-level-data.
En: Obstet Gynecol 106 (1): 181-189, jul. 2005
145. Contemporary treatments for twin-twin transfusion syndrome.
En: Obstet Gynecol 105 (6): 1469-1477, jun. 2005
146. Immunogenetic determinants of preeclampsia and related pregnancy disorders : A systematic review.
En: Obstet Gynecol 106 (1): 162-172, jul. 2005
147. Reclosure of the disrupted laparotomy wound : A systematic review.
En: Obstet Gynecol 106 (2): 376-383, ago. 2005
148. Management of first and second stages of labor.
En: Obstet Gynecol Clin North Am 32 (2): jun. 2005
149. Diagnosis and management of skin cancer.
En: Oral Maxillof Surg Clin
North Am 17 (2): mayo. 2005
150. Cisticercosis subcutánea : parasitosis letal y emergente.
En: Piel 20 (4): 177-182, abr. 2005
151. Ulcera de Buruli.
En: Piel 20 (5): 223-230, mayo. 2005
152. Symposium on addiction.
En: Postgrad Med 118 (1): jul. 2005
153. Symposium on allergy.
En: Postgrad Med 117 (5): mayo. 2005
154. Symposium on peptic acid disease.
En: Postgrad Med 117 (6): jun. 2005
155. Evolución del concepto de esquizofaxia.
En: Psiq Biol 12 (3): 106-116, mayo-jun. 2005
156. Significado clínico de las alteraciones analíticas en el síndrome Sjögren.
En: Rev Esp Reumatol 32 (3): 134-146,
mar-abr. 2005
157. Reumatismo palindrómico : ¿entidad independiente o forma frustrada de artritis reumatoide?.
En: Rev Esp Reumatol 32 (3): 147-151, mar-abr. 2005
158. Dry eye.
En: Semin Ophthalmol 20 (2): abr-jun. 2005
159. Thymic Tumors.
En: Semin Thorac Cardiovasc Surg 17 (1): 2005
160. Anticoagulation advances and Heparin-Induced Thrombocytopenia.
En: Semin Thorac Cardiovasc Surg 17 (1): 2005
161. Carotid stenting : Indications, technique, training, credentialing.
En: Semin Vasc Surg 18 (2): jun. 2005
162. Esophageal surgery.
En: Surg Clin North Am 85 (3): jun. 2005
163. Contemporary issues and management of bladder cancer.
En: Urol Clin North Am 32 (2): mayo. 2005
BIBLIOTECA MEDICA- HOSPITAL MEXICO
TEL/FAX:232-62-16, APDO: 523-1150
E-MAIL: biliomexico@hotmail.com